Advertisement

Complications of Solid Organ Transplantation

Cardiovascular, Neurologic, Renal, and Gastrointestinal
Published:October 25, 2018DOI:https://doi.org/10.1016/j.ccc.2018.08.011

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kellar C.A.
        Solid organ transplantation overview and delection criteria.
        Am J Manag Care. 2015; 21: S4-S11
        • Bloom R.D.
        • Goldberg L.R.
        • Wang A.Y.
        • et al.
        An overview of solid organ transplantation.
        Clin Chest Med. 2005; 26 (v): 529-543
        • Linden P.K.
        History of solid organ transplantation and organ donation.
        Crit Care Clin. 2009; 25 (ix): 165-184
        • Rana A.
        • Gruessner A.
        • Agopian V.G.
        • et al.
        Survival benefit of solid-organ transplant in the United States.
        JAMA Surg. 2015; 150: 252-259
        • Foley R.N.
        • Parfrey P.S.
        • Sarnak M.J.
        Clinical epidemiology of cardiovascular disease in chronic renal disease.
        Am J Kidney Dis. 1998; 32: S112-S119
        • Munagala M.R.
        • Phancao A.
        Managing cardiovascular risk in the post solid organ transplant recipient.
        Med Clin North Am. 2016; 100: 519-533
        • Gillis K.A.
        • Patel R.K.
        • Jardine A.G.
        Cardiovascular complications after transplantation: treatment options in solid organ recipients.
        Transplant Rev (Orlando). 2014; 28: 47-55
        • Israni A.K.
        • Snyder J.J.
        • Skeans M.A.
        • et al.
        Predicting coronary heart disease after kidney transplantation: patient outcomes in renal transplantation (PORT) study.
        Am J Transplant. 2010; 10: 338-353
        • Kasiske B.L.
        • Maclean J.R.
        • Snyder J.J.
        Acute myocardial infarction and kidney transplantation.
        J Am Soc Nephrol. 2006; 17: 900-907
        • Lentine K.L.
        • Brennan D.C.
        • Schnitzler M.A.
        Incidence and predictors of myocardial infarction after kidney transplantation.
        J Am Soc Nephrol. 2005; 16: 496-506
        • Tiukinhoy-Laing S.D.
        • Rossi J.S.
        • Bayram M.
        • et al.
        Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation.
        Am J Cardiol. 2006; 98: 178-181
        • Boggi U.
        • Vistoli F.
        • Amorese G.
        • et al.
        Long-term (5 years) efficacy and safety of pancreas transplantation alone in type 1 diabetic patients.
        Transplantation. 2012; 93: 842-846
        • Larsen J.L.
        • Colling C.W.
        • Ratanasuwan T.
        • et al.
        Pancreas transplantation improves vascular disease in patients with type 1 diabetes.
        Diabetes Care. 2004; 27: 1706-1711
        • Studer S.M.
        • Levy R.D.
        • McNeil K.
        • et al.
        Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness.
        Eur Respir J. 2004; 24: 674-685
        • Hertz M.I.
        • Taylor D.O.
        • Trulock E.P.
        • et al.
        The registry of the International Society for Heart and Lung Transplantation: nineteenth official report-2002.
        J Heart Lung Transplant. 2002; 21: 950-970
        • Oberbauer R.
        • Segoloni G.
        • Campistol J.M.
        • et al.
        Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.
        Transpl Int. 2005; 18: 22-28
        • Vanrenterghem Y.
        • Bresnahan B.
        • Campistol J.
        • et al.
        Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies).
        Transplantation. 2011; 91: 976-983
        • Midtvedt K.
        • Ihlen H.
        • Hartmann A.
        • et al.
        Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study.
        Transplantation. 2001; 72: 107-111
        • Heinze G.
        • Mitterbauer C.
        • Regele H.
        • et al.
        Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
        J Am Soc Nephrol. 2006; 17: 889-899
        • Opelz G.
        • Zeier M.
        • Laux G.
        • et al.
        No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report.
        J Am Soc Nephrol. 2006; 17: 3257-3262
        • Philipp T.
        • Martinez F.
        • Geiger H.
        • et al.
        Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.
        Nephrol Dial Transplant. 2010; 25: 967-976
        • Opelz G.
        • Dohler B.
        • Collaborative Transplant S.
        Improved long-term outcomes after renal transplantation associated with blood pressure control.
        Am J Transplant. 2005; 5: 2725-2731
        • Kidney Disease: Improving Global Outcomes Transplant Work Group
        KDIGO clinical practice guideline for the care of kidney transplant recipients.
        Am J Transplant. 2009; 9: S1-S155
        • Pascual J.
        • Zamora J.
        • Galeano C.
        • et al.
        Steroid avoidance or withdrawal for kidney transplant recipients.
        Cochrane Database Syst Rev. 2009; (CD005632)
        • Pestana J.O.
        • Grinyo J.M.
        • Vanrenterghem Y.
        • et al.
        Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys.
        Am J Transplant. 2012; 12: 630-639
        • Symplicity H.T.N.I.
        • Esler M.D.
        • Krum H.
        • et al.
        Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
        Lancet. 2010; 376: 1903-1909
        • Alba C.
        • Bain E.
        • Ng N.
        • et al.
        Complications after heart transplantation: hope for the best, but prepare for the worst.
        Int J Transplant Res Med. 2016; 2: 022
        • Ballantyne C.
        Clinical lipidology: a companion to Braunwald's heart disease; special populations: transplant recipients.
        Saunders, 2009
        • Tse K.C.
        • Lam M.F.
        • Yip P.S.
        • et al.
        A long-term study on hyperlipidemia in stable renal transplant recipients.
        Clin Transplant. 2004; 18: 274-280
        • Ghanem H.
        • van den Dorpel M.A.
        • Weimar W.
        • et al.
        Increased low density lipoprotein oxidation in stable kidney transplant recipients.
        Kidney Int. 1996; 49: 488-493
        • Kasiske B.L.
        Hyperlipidemia in patients with chronic renal disease.
        Am J Kidney Dis. 1998; 32: S142-S156
        • Blum C.B.
        Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model.
        Am J Transplant. 2002; 2: 551-559
        • Holdaas H.
        • Fellstrom B.
        • Cole E.
        • et al.
        Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.
        Am J Transplant. 2005; 5: 2929-2936
        • Baigent C.
        • Landray M.J.
        • Reith C.
        • et al.
        The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
        Lancet. 2011; 377: 2181-2192
        • Weiner D.E.
        • Carpenter M.A.
        • Levey A.S.
        • et al.
        Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial.
        Am J Transplant. 2012; 12: 2437-2445
        • Bloom R.D.
        • Doyle A.M.
        Kidney disease after heart and lung transplantation.
        Am J Transplant. 2006; 6: 671-679
        • Cole E.H.
        • Johnston O.
        • Rose C.L.
        • et al.
        Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival.
        Clin J Am Soc Nephrol. 2008; 3: 814-821
        • Cosio F.G.
        • Pesavento T.E.
        • Osei K.
        • et al.
        Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.
        Kidney Int. 2001; 59: 732-737
        • Rakel A.
        • Karelis A.D.
        New-onset diabetes after transplantation: risk factors and clinical impact.
        Diabetes Metab. 2011; 37: 1-14
        • Vincenti F.
        • Friman S.
        • Scheuermann E.
        • et al.
        Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.
        Am J Transplant. 2007; 7: 1506-1514
        • Kasiske B.L.
        • Guijarro C.
        • Massy Z.A.
        • et al.
        Cardiovascular disease after renal transplantation.
        J Am Soc Nephrol. 1996; 7: 158-165
        • Hjelmesaeth J.
        • Hartmann A.
        • Kofstad J.
        • et al.
        Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.
        Transplantation. 1997; 64: 979-983
        • Montori V.M.
        • Basu A.
        • Erwin P.J.
        • et al.
        Posttransplantation diabetes: a systematic review of the literature.
        Diabetes Care. 2002; 25: 583-592
        • Nissen S.E.
        • Wolski K.
        Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
        N Engl J Med. 2007; 356: 2457-2471
        • Werzowa J.
        • Hecking M.
        • Haidinger M.
        • et al.
        Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial.
        Transplantation. 2013; 95: 456-462
        • Wilkinson A.
        • Davidson J.
        • Dotta F.
        • et al.
        Guidelines for the treatment and management of new-onset diabetes after transplantation.
        Clin Transplant. 2005; 19: 291-298
        • Gerstein H.C.
        • Miller M.E.
        • Byington R.P.
        • et al.
        • Action to Control Cardiovascular Risk in Diabetes Study Group
        Effects of intensive glucose lowering in type 2 diabetes.
        N Engl J Med. 2008; 358: 2545-2559
        • Oufroukhi L.
        • Kamar N.
        • Muscari F.
        • et al.
        Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation.
        Transplantation. 2008; 85: 1436-1442
        • Laish I.
        • Braun M.
        • Mor E.
        • et al.
        Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events.
        Liver Transpl. 2011; 17: 15-22
        • Vincenti F.
        • Charpentier B.
        • Vanrenterghem Y.
        • et al.
        A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
        Am J Transplant. 2010; 10: 535-546
        • Modanlou K.A.
        • Muthyala U.
        • Xiao H.
        • et al.
        Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review.
        Transplantation. 2009; 87: 1167-1173
        • Golomb I.
        • Winkler J.
        • Ben-Yakov A.
        • et al.
        Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation.
        Am J Transplant. 2014; 14: 2384-2390
        • Costanzo M.R.
        • Dipchand A.
        • Starling R.
        • et al.
        The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients.
        J Heart Lung Transplant. 2010; 29: 914-956
        • Kobashigawa J.
        • Crespo-Leiro M.G.
        • Ensminger S.M.
        • et al.
        Report from a consensus conference on antibody-mediated rejection in heart transplantation.
        J Heart Lung Transplant. 2011; 30: 252-269
        • Nwakanma L.U.
        • Williams J.A.
        • Weiss E.S.
        • et al.
        Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era.
        Ann Thorac Surg. 2007; 84 ([discussion: 62–3]): 1556-1562
        • Smith J.D.
        • Banner N.R.
        • Hamour I.M.
        • et al.
        De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.
        Am J Transplant. 2011; 11: 312-319
        • Fishbein M.C.
        • Kobashigawa J.
        Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy.
        Curr Opin Cardiol. 2004; 19: 166-169
        • Lund L.H.
        • Edwards L.B.
        • Kucheryavaya A.Y.
        • et al.
        The registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report—2013; focus theme: age.
        J Heart Lung Transplant. 2013; 32: 951-964
        • Yusen R.D.
        • Edwards L.B.
        • Kucheryavaya A.Y.
        • et al.
        The registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report--2015; focus theme: early graft failure.
        J Heart Lung Transplant. 2015; 34: 1264-1277
        • Ramzy D.
        • Rao V.
        • Brahm J.
        • et al.
        Cardiac allograft vasculopathy: a review.
        Can J Surg. 2005; 48: 319-327
        • Mehra M.R.
        • Crespo-Leiro M.G.
        • Dipchand A.
        • et al.
        International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010.
        J Heart Lung Transplant. 2010; 29: 717-727
        • Akosah K.O.
        • Mohanty P.K.
        • Funai J.T.
        • et al.
        Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography.
        J Heart Lung Transplant. 1994; 13: 1024-1038
        • Vakil K.
        • Taimeh Z.
        • Sharma A.
        • et al.
        Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation.
        Heart Rhythm. 2014; 11: 1684-1690
        • Kobashigawa J.A.
        • Moriguchi J.D.
        • Laks H.
        • et al.
        Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
        J Heart Lung Transplant. 2005; 24: 1736-1740
        • Arora S.
        • Andreassen A.K.
        • Andersson B.
        • et al.
        The effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo recipients: one-year results of a Scandinavian randomized trial.
        Am J Transplant. 2015; 15: 1967-1975
        • Kobashigawa J.A.
        • Pauly D.F.
        • Starling R.C.
        • et al.
        Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the everolimus versus mycophenolate mofetil randomized, multicenter trial.
        JACC Heart Fail. 2013; 1: 389-399
        • Senzolo M.
        • Ferronato C.
        • Burra P.
        Neurologic complications after solid organ transplantation.
        Transpl Int. 2009; 22: 269-278
        • Pizzi M.
        • Ng L.
        Neurologic complications of solid organ transplantation.
        Neurol Clin. 2017; 35: 809-823
        • Pedroso J.L.
        • Dutra L.A.
        • Braga-Neto P.
        • et al.
        Neurological complications of solid organ transplantation.
        Arq Neuropsiquiatr. 2017; 75: 736-747
        • Dhar R.
        • Human T.
        Central nervous system complications after transplantation.
        Neurol Clin. 2011; 29: 943-972
        • Wijdicks E.F.
        • Wiesner R.H.
        • Krom R.A.
        Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression.
        Neurology. 1995; 45: 1962-1964
        • Bronster D.J.
        • Emre S.
        • Boccagni P.
        • et al.
        Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up.
        Clin Transplant. 2000; 14: 1-7
        • Anghel D.
        • Tanasescu R.
        • Campeanu A.
        • et al.
        Neurotoxicity of immunosuppressive therapies in organ transplantation.
        Maedica (Buchar). 2013; 8: 170-175
        • Ciecko-Michalska I.
        • Szczepanek M.
        • Slowik A.
        • et al.
        Pathogenesis of hepatic encephalopathy.
        Gastroenterol Res Pract. 2012; 2012: 642108
        • Lewis M.B.
        • Howdle P.D.
        Neurologic complications of liver transplantation in adults.
        Neurology. 2003; 61: 1174-1178
        • Shigemura N.
        • Sclabassi R.J.
        • Bhama J.K.
        • et al.
        Early major neurologic complications after lung transplantation: incidence, risk factors, and outcome.
        Transplantation. 2013; 95: 866-871
        • Kim J.M.
        • Jung K.H.
        • Lee S.T.
        • et al.
        Central nervous system complications after liver transplantation.
        J Clin Neurosci. 2015; 22: 1355-1359
        • Conti D.J.
        • Rubin R.H.
        Infection of the central nervous system in organ transplant recipients.
        Neurol Clin. 1988; 6: 241-260
        • van de Beek D.
        • Patel R.
        • Daly R.C.
        • et al.
        Central nervous system infections in heart transplant recipients.
        Arch Neurol. 2007; 64: 1715-1720
        • Pustavoitau A.
        • Bhardwaj A.
        • Stevens R.
        Neurological complications of transplantation.
        J Intensive Care Med. 2011; 26: 209-222
        • Alejaldre A.
        • Delgado-Mederos R.
        • Santos M.A.
        • et al.
        Cerebrovascular complications after heart transplantation.
        Curr Cardiol Rev. 2010; 6: 214-217
        • Fugate J.E.
        • Rabinstein A.A.
        Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.
        Lancet Neurol. 2015; 14: 914-925
        • Gilmore R.L.
        Seizures and antiepileptic drug use in transplant patients.
        Neurol Clin. 1988; 6: 279-296
        • Patchell R.A.
        Neurological complications of organ transplantation.
        Ann Neurol. 1994; 36: 688-703
        • Frontera J.A.
        • Kalb T.
        Neurological management of fulminant hepatic failure.
        Neurocrit Care. 2011; 14: 318-327
        • Fukazawa K.
        • Nishida S.
        • Aguina L.
        • et al.
        Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation.
        Ann Transplant. 2011; 16: 139-142
        • Fryer J.P.
        • Fortier M.V.
        • Metrakos P.
        • et al.
        Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation.
        Transplantation. 1996; 61: 658-661
        • Miller B.W.
        Chronic kidney disease in solid-organ transplantation.
        Adv Chronic Kidney Dis. 2006; 13: 29-34
        • Srinivas T.R.
        • Stephany B.R.
        • Budev M.
        • et al.
        An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation.
        Clin J Am Soc Nephrol. 2010; 5: 1881-1886
        • O'Riordan A.
        • Wong V.
        • McCormick P.A.
        • et al.
        Chronic kidney disease post-liver transplantation.
        Nephrol Dial Transplant. 2006; 21: 2630-2636
        • Nadkarni G.N.
        • Chauhan K.
        • Patel A.
        • et al.
        Temporal trends of dialysis requiring acute kidney injury after orthotopic cardiac and liver transplant hospitalizations.
        BMC Nephrol. 2017; 18: 244
        • Arnaoutakis G.J.
        • George T.J.
        • Robinson C.W.
        • et al.
        Severe acute kidney injury according to the RIFLE (risk, injury, failure, loss, end stage) criteria affects mortality in lung transplantation.
        J Heart Lung Transplant. 2011; 30: 1161-1168
        • Bloom R.D.
        Renal function and nonrenal solid organ transplantation.
        Wolters Kulwer Health, The Netherlands2016 (Available at:)
        • De Santo L.S.
        • Romano G.
        • Amarelli C.
        • et al.
        Implications of acute kidney injury after heart transplantation: what a surgeon should know.
        Eur J Cardiothorac Surg. 2011; 40 ([discussion: 61]): 1355-1361
        • Schiferer A.
        • Zuckermann A.
        • Dunkler D.
        • et al.
        Acute kidney injury and outcome after heart transplantation: large differences in performance of scoring systems.
        Transplantation. 2016; 100: 2439-2446
        • Jochmans I.
        • Meurisse N.
        • Neyrinck A.
        • et al.
        Hepatic ischemia/reperfusion injury associates with acute kidney injury in liver transplantation: prospective cohort study.
        Liver Transpl. 2017; 23: 634-644
        • Puschett J.B.
        • Greenberg A.
        • Holley J.
        • et al.
        The spectrum of ciclosporin nephrotoxicity.
        Am J Nephrol. 1990; 10: 296-309
        • Xia T.
        • Zhu S.
        • Wen Y.
        • et al.
        Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis.
        Drug Des Devel Ther. 2018; 12: 417-428
        • Bacchi G.
        • Buscaroli A.
        • Fusari M.
        • et al.
        The influence of intraoperative central venous pressure on delayed graft function in renal transplantation: a single-center experience.
        Transplant Proc. 2010; 42: 3387-3391
        • Stigant C.E.
        • Cohen J.
        • Vivera M.
        • et al.
        ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
        Am J Kidney Dis. 2000; 35: 58-63
        • Asrani S.K.
        • Wiesner R.H.
        • Trotter J.F.
        • et al.
        De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.
        Am J Transplant. 2014; 14: 356-366
        • Cassuto J.R.
        • Reese P.P.
        • Sonnad S.
        • et al.
        Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients.
        Am J Transplant. 2010; 10: 2502-2511
        • Chandok N.
        • Wyat K.
        Gastrointestinal complications of solid organ and hematopoietic cell transplantation.
        in: Talley N.J. Kane S.V. Wallace M.B. Practical gastroenterology and hepatology board review toolkit. 2nd edition. John Wiley and Sons Ltd, Hoboken (NJ)2016: 419-424
        • Gautam A.
        Gastrointestinal complications following transplantation.
        Surg Clin North Am. 2006; 86 (vii): 1195-1206
        • Fischer S.A.
        Infections complicating solid organ transplantation.
        Surg Clin North Am. 2006; 86 (v-vi): 1127-1145
        • Snydman D.R.
        Infection in solid organ transplantation.
        Transpl Infect Dis. 1999; 1: 21-28
        • Lowance D.
        • Neumayer H.H.
        • Legendre C.M.
        • et al.
        Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
        N Engl J Med. 1999; 340: 1462-1470
        • Mitchell O.
        • Gurakar A.
        Management of hepatitis C post-liver transplantation: a comprehensive review.
        J Clin Transl Hepatol. 2015; 3: 140-148
        • Veldt B.J.
        • Poterucha J.J.
        • Watt K.D.
        • et al.
        Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection.
        Am J Transplant. 2008; 8: 2426-2433
        • Reese J.
        • Burton F.
        • Lingle D.
        • et al.
        Peptic ulcer disease following renal transplantation in the cyclosporine era.
        Am J Surg. 1991; 162: 558-562
        • Stelzner M.
        • Vlahakos D.V.
        • Milford E.L.
        • et al.
        Colonic perforations after renal transplantation.
        J Am Coll Surg. 1997; 184: 63-69
        • Gutierrez-Dalmau A.
        • Campistol J.M.
        Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.
        Drugs. 2007; 67: 1167-1198